Page last updated: 2024-11-03

4-aminobenzoic acid and Arrhythmias, Cardiac

4-aminobenzoic acid has been researched along with Arrhythmias, Cardiac in 3 studies

para-Aminobenzoates: Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
4-aminobenzoate : An aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research Excerpts

ExcerptRelevanceReference
"CHF6001 is an inhaled PDE4 inhibitor with proven anti-inflammatory properties in animal models."6.82Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers. ( Compagnoni, A; Ferrari, A; Maison-Blanche, P; Nandeuil, A, 2016)
"CHF6001 is an inhaled PDE4 inhibitor with proven anti-inflammatory properties in animal models."2.82Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers. ( Compagnoni, A; Ferrari, A; Maison-Blanche, P; Nandeuil, A, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrari, A1
Compagnoni, A1
Nandeuil, A1
Maison-Blanche, P1
SOMANI, P1
LUM, BK1
SIGG, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Placebo-controlled Double-blind Single and Repeated Ascending Dose Study to Investigate the Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers[NCT01703052]Phase 174 participants (Actual)Interventional2011-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 4-aminobenzoic acid and Arrhythmias, Cardiac

ArticleYear
Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers.
    Journal of cardiovascular pharmacology, 2016, Volume: 68, Issue:1

    Topics: Action Potentials; Administration, Inhalation; Arrhythmias, Cardiac; Cross-Over Studies; Double-Blin

2016

Other Studies

2 other studies available for 4-aminobenzoic acid and Arrhythmias, Cardiac

ArticleYear
THE ANTIARRHYTHMIC ACTIONS OF BETA ADRENERGIC BLOCKING AGENTS.
    The Journal of pharmacology and experimental therapeutics, 1965, Volume: 147

    Topics: Adrenergic beta-Antagonists; Aminobenzoates; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pre

1965
[Therapeutic anesthesia with panthesin in asthma. angina pectoris, cardiac arrhythmia, polyarthritis, &c].
    Schweizerische medizinische Wochenschrift, 1951, Jan-06, Volume: 81, Issue:1

    Topics: Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Arthritis; Asthma; Brugada Syndrome; Cardiac Cond

1951